Skip to main content
. 2022 Dec 15;280(5):2351–2358. doi: 10.1007/s00405-022-07788-8

Table 1.

Epidemiological and clinical characteristics of patients

Outcomes Patients (N = 87)
Age (mean, SD—years) 41.6 ± 14.6
Sex (N (%))
 Male 25 (28.7)
 Female 62 (71.3)
Comorbidities [N (%)]
 Thyroid disorder 14 (16.1)
 Hypertension 8 (9.2)
 Arthrosis 8 (9.2)
 Diabetes 8 (9.2)
 Hypercholesterolemia 7 (8.0)
 Depression 5 (5.7)
 Psoriasis 5 (5.7)
 Asthma 4 (4.6)
 Reflux 4 (4.6)
 Renal insufficiency 2 (2.3)
 Rheumatoid polyarthritis 2 (2.3)
 Cancer history 1 (1.1)
 Hepatic insufficiency 1 (1.1)
 Cardiologic affections 1 (1.1)
 Allergy 5 (5.7)
 Tobacco consumption 4 (4.6)
Vaccine [N (%)]
 No response 13 (14.9)
 No vaccine 14 (16.1)
 One-dose vaccine 5 (5.7)
 Two-dose vaccine 20 (23.0)
 Three-dose vaccine 35 (40.2)

N number, SD standard deviation